Swissmedic On Project Orbis: Faster Access To Drugs, Valuable Scientific Discussions

In the first of a two-part interview with the Pink Sheet, an expert from the Swiss drug regulator explains why international collaborations are “the future” and outlines the agency’s “extremely positive” experience since joining the Project Orbis initiative three years ago.

Swiss flag pills
• Source: Shutterstock

The US-led Project Orbis was initiated by the Food and Drug Administration in May 2019, with the aim of establishing a framework for international regulators to concurrently review filings for cancer drugs.

Its ultimate goal was to allow patients with cancer to receive earlier access to innovative oncology medicines by avoiding delays...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography